K08670903

Kromasil^®Eternity^™C18 HPLCカラム

5 μm particle size, pore size 100 Å, L × I.D. 250 mm × 4.6 mm

• 別名: Kromasil C18
• UNSPSCコード: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

特性

• 認証: suitable for USP L1
• 製品種目: Kromasil^®
• メーカー／製品名: Kromasil^® ET-5-C18-4.6X250
• 利用可能性: available only in USA, Canada and Puerto Rico
• 標識化の程度: 14% Carbon loading
• テクニック: HPLC: suitable
• L × 内径: 250 mm × 4.6 mm
• 表面積: 330 m²/g
• マトリックス活性基: C18 (octadecyl) phase
• 粒径: 5 μm
• ポアサイズ: 100 Å
• pH範囲: 1-12
• アプリケーション: food and beverages
• 分離法: reversed phase

詳細

アプリケーション

• Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.: This study developed and validated an HPLC-MS/MS method for determining clopidogrel in human plasma. The Kromasil^® Eternity C18 HPLC column was employed to achieve the separation. This method was shown to be efficient, precise, and suitable for pharmacokinetic studies (Liu et al., 2016).


• Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.: The study focused on developing a stability-indicating assay method for atorvastatin and ezetimibe using UPLC. The Kromasil^® Eternity C18 HPLC column was critical in achieving the required resolution and sensitivity, demonstrating its role in stability studies of pharmaceutical combinations (Goel et al., 2013).

法的情報

Eternity is a trademark of EKA Chemicals AB

Kromasil is a registered trademark of EKA Chemicals AB